Autres langues Kronos Bio, Inc.

Actions

KRON

US50107A1043

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
1 ^USD	+2,04%		-0,99%	-20,00%

21/03	Kronos Bio, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023	CI
21/03	Kronos Bio, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M	21/03
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results	21/03
Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
Kronos Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway	07/03
Kronos Bio, Inc. Announces to Assess KB-0742 At Planned New Dose Schedule in Ongoing Phase 1/2 Study	07/03
Kronos Bio Plans to Reduction in Force	07/03
Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting	05/03
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	27/02
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	27/02
Kronos Bio Announces Management Shakeup, 3 Top Managers to Step Down in February	25/01
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement	25/01
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement	25/01
Kronos Bio, Inc. Announces Executive Changes	25/01
Investors got more clues that rate cuts are imminent	19/12
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	18/12
Kronos Bio, Inc. Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	18/12
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	04/12
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	04/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kronos Bio, Inc.

Actions

KRON

US50107A1043

Autres langues

Filtres